A Phase II Study of Single-agent DOVitinib in Advanced Malignant PlEural Mesothelioma Which Has Progressed Following Prior Platinum-Antifolate Chemotherapy
Clinical trial NCT01769547 · TERMINATED
Trial details
- NCT number
- NCT01769547
- Sponsor
- Ontario Clinical Oncology Group (OCOG)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2015-06-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.